Protein C activated (Kaketsuken/Teijin)

人活化蛋白C

Report date: 2022/01/14 13:23:58

Base Information

Drug NameProtein C activated (Kaketsuken/Teijin)
Drug Alias NameActivated protein C (Kaketsuken/Teijin)CTC-111Anact C
ClassificationBiologics > Blood components
Mechanisms of ActionProtein C replacementsCoagulation factor VIII inhibitorsFactor Va inhibitors
TargetsCoagulation factor VCoagulation factor VIII
Therapy Area/IndicationsPurpuraVenous ThrombosisPulmonary Embolism
Global Approved IndicationsPurpuraVenous ThrombosisPulmonary Embolism
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2000/09/22
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKM Biologics Co LtdTeijin Pharma
China Registration ClassN/A

Develop Information

Active CompaniesKM Biologics Co Ltd
Inactive CompaniesN/A
Active IndicationsPurpuraVenous ThrombosisPulmonary Embolism
Inactive IndicationsN/A

Other Information

ATC CodeB01AD12
Related LinksWikipediaKEGG